Our results extended previous observations and found that miR-140-5p in osteosarcoma enhanced the chemoresistance by up-regulating HMGN5-mediated autophagy, suggesting that miR-140-5p is a potential target of an adjuvant therapy for osteosarcoma patients. Here, HMGN5 is linked to osteosarcoma.